259 related articles for article (PubMed ID: 23837856)
21. Shape matters: Biodegradable anisotropic nanoparticle artificial antigen presenting cells for cancer immunotherapy.
Ben-Akiva E; Hickey JW; Meyer RA; Isser A; Shannon SR; Livingston NK; Rhodes KR; Kosmides AK; Warren TR; Tzeng SY; Schneck JP; Green JJ
Acta Biomater; 2023 Apr; 160():187-197. PubMed ID: 36812956
[TBL] [Abstract][Full Text] [Related]
22. Artificial antigen-presenting cells are superior to dendritic cells at inducing antigen-specific cytotoxic T lymphocytes.
Shao J; Xu Q; Su S; Wei J; Meng F; Chen F; Zhao Y; Du J; Zou Z; Qian X; Liu B
Cell Immunol; 2018 Dec; 334():78-86. PubMed ID: 30392890
[TBL] [Abstract][Full Text] [Related]
23. Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles.
Hickey JW; Schneck JP
J Vis Exp; 2018 Nov; (141):. PubMed ID: 30507913
[TBL] [Abstract][Full Text] [Related]
24. Surface-Engineering of Red Blood Cells as Artificial Antigen Presenting Cells Promising for Cancer Immunotherapy.
Sun X; Han X; Xu L; Gao M; Xu J; Yang R; Liu Z
Small; 2017 Oct; 13(40):. PubMed ID: 28861943
[TBL] [Abstract][Full Text] [Related]
25. Cell-Templated Silica Microparticles with Supported Lipid Bilayers as Artificial Antigen-Presenting Cells for T Cell Activation.
Olden BR; Perez CR; Wilson AL; Cardle II; Lin YS; Kaehr B; Gustafson JA; Jensen MC; Pun SH
Adv Healthc Mater; 2019 Jan; 8(2):e1801188. PubMed ID: 30549244
[TBL] [Abstract][Full Text] [Related]
26. Efficient amplification of melanoma-specific CD8+ T cells using artificial antigen presenting complex.
Chang J
Exp Mol Med; 2006 Dec; 38(6):591-8. PubMed ID: 17202834
[TBL] [Abstract][Full Text] [Related]
27. Ex vivo induction and expansion of antigen-specific cytotoxic T cells by HLA-Ig-coated artificial antigen-presenting cells.
Oelke M; Maus MV; Didiano D; June CH; Mackensen A; Schneck JP
Nat Med; 2003 May; 9(5):619-24. PubMed ID: 12704385
[TBL] [Abstract][Full Text] [Related]
28. Artificial antigen-presenting cells transduced with telomerase efficiently expand epitope-specific, human leukocyte antigen-restricted cytotoxic T cells.
Dupont J; Latouche JB; Ma C; Sadelain M
Cancer Res; 2005 Jun; 65(12):5417-27. PubMed ID: 15958591
[TBL] [Abstract][Full Text] [Related]
29. Cytotoxic minor histocompatibility antigen HA-1-specific CD8+ effector memory T cells: artificial APCs pave the way for clinical application by potent primary in vitro induction.
Schilbach K; Kerst G; Walter S; Eyrich M; Wernet D; Handgretinger R; Xie W; Rammensee HG; Müller I; Bühring HJ; Niethammer D
Blood; 2005 Jul; 106(1):144-9. PubMed ID: 15731181
[TBL] [Abstract][Full Text] [Related]
30. Fabrication of Anisotropic Polymeric Artificial Antigen Presenting Cells for CD8+ T Cell Activation.
Ben-Akiva E; Rhodes KR; Meyer RA; Green JJ
J Vis Exp; 2018 Oct; (140):. PubMed ID: 30371668
[TBL] [Abstract][Full Text] [Related]
31. γδ T cells cultured with artificial antigen-presenting cells and IL-2 show long-term proliferation and enhanced effector functions compared with γδ T cells cultured with only IL-2 after stimulation with zoledronic acid.
Choi H; Lee Y; Hur G; Lee SE; Cho HI; Sohn HJ; Cho BS; Kim HJ; Kim TG
Cytotherapy; 2021 Oct; 23(10):908-917. PubMed ID: 34312069
[TBL] [Abstract][Full Text] [Related]
32. [Activation of specific T lymphocyte induced by artificial antigen presenting cell complex in vitro].
Mao HW; Liu WL; Zhou JF; Geng Z; Huang W
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):655-8. PubMed ID: 18549648
[TBL] [Abstract][Full Text] [Related]
33. Artificial Antigen-Presenting Cell Topology Dictates T Cell Activation.
Wauters AC; Scheerstra JF; Vermeijlen IG; Hammink R; Schluck M; Woythe L; Wu H; Albertazzi L; Figdor CG; Tel J; Abdelmohsen LKEA; van Hest JCM
ACS Nano; 2022 Sep; 16(9):15072-15085. PubMed ID: 35969506
[TBL] [Abstract][Full Text] [Related]
34. Immunotherapy for Tumor Metastasis by Artificial Antigen-Presenting Cells via Targeted Microenvironment Regulation and T-Cell Activation.
Lu Y; Li L; Du J; Chen J; Xu X; Yang X; Ding C; Mao C
ACS Appl Mater Interfaces; 2021 Dec; 13(47):55890-55901. PubMed ID: 34787393
[TBL] [Abstract][Full Text] [Related]
35. Generation of Pure Highly Functional Human Anti-Tumor Specific Cytotoxic T Lymphocytes With Stem Cell-Like Memory Features for Melanoma Immunotherapy.
Hamieh M; Chatillon JF; Dupel E; Bayeux F; Fauquembergue E; Maby P; Drouet A; Duval-Modeste AB; Adriouch S; Boyer O; Latouche JB
Front Immunol; 2021; 12():674276. PubMed ID: 34566953
[TBL] [Abstract][Full Text] [Related]
36. Selection of HLA-A2 restricted CML28 peptide by artificial antigen-presenting cells.
Mao H; Geng Z; Liu W; Sun H; Huang W
J Immunother; 2008 Jun; 31(5):487-90. PubMed ID: 18463536
[TBL] [Abstract][Full Text] [Related]
37. Artificial antigen presenting cells that express prevalent HLA alleles: A step towards the broad application of antigen-specific adoptive cell therapies.
Hasan AN; Selvakumar A; Doubrovina E; Riviere I; Sadelain MW; O'Reilly RJ
Discov Med; 2009 Dec; 8(43):210-8. PubMed ID: 20040272
[TBL] [Abstract][Full Text] [Related]
38. An Artificial Antigen-Presenting Cell Delivering 11 Immune Molecules Expands Tumor Antigen-Specific CTLs in
Zhang L; Song S; Jin X; Wan X; Shahzad KA; Pei W; Zhao C; Shen C
Cancer Immunol Res; 2019 Jul; 7(7):1188-1201. PubMed ID: 31113806
[TBL] [Abstract][Full Text] [Related]
39. Adoptive immunotherapy: good habits instilled at youth have long-term benefits.
Paulos CM; Suhoski MM; Plesa G; Jiang T; Basu S; Golovina TN; Jiang S; Aqui NA; Powell DJ; Levine BL; Carroll RG; Riley JL; June CH
Immunol Res; 2008; 42(1-3):182-96. PubMed ID: 18949448
[TBL] [Abstract][Full Text] [Related]
40. CD47 Enhances In Vivo Functionality of Artificial Antigen-Presenting Cells.
Bruns H; Bessell C; Varela JC; Haupt C; Fang J; Pasemann S; Mackensen A; Oelke M; Schneck JP; Schütz C
Clin Cancer Res; 2015 May; 21(9):2075-83. PubMed ID: 25593301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
